Dr. Ganesh Gopalakrishna, MD

Dr. Gopalakrishna practices at Banner Alzheimer's Institute in Sun City, Arizona.

Dr. Gopalakrishna's NPI, 1891995262, was assigned on July 23, 2007. Dr. Gopalakrishna graduated from Bangalore Medical College in 2005. Dr. Gopalakrishna's Missouri license number on file is 2007010592.

Dr. Gopalakrishna's primary practice is Banner Alzheimer's Institute, at 10515 W Santa Fe Dr Bldg B 1st Floor Bldg B, Sun City, AZ 85351-3020. The practice phone is (623) 832-6530.

Dr. Gopalakrishna's primary practice is Banner Alzheimer's Institute in Sun City, Arizona. Dr. Gopalakrishna is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Alzheimer's Institute. Dmand AI also links Dr. Gopalakrishna to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gopalakrishna practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Gopalakrishna's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Gopalakrishna is board certified in addiction medicine by the American Board of Preventive Medicine. Dmand AI has Dr. Gopalakrishna's licenses on file in 3 states: Missouri, Arizona and Tennessee.

Dmand AI lists anxiety, depression and non-alzheimer's dementia (chronic) among the conditions Dr. Gopalakrishna treats.

CMS data shows 245 Medicare services from Dr. Gopalakrishna across 3 procedure codes in 2024, all of them office visits, for 173 Medicare patients. Medicare paid $30,056 for them. Every service was in an office.

CMS counts 173 Medicare patients who saw Dr. Gopalakrishna in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gopalakrishna's median patient age at 76, with 58% women.

In 2024, Dr. Gopalakrishna wrote 776 Medicare Part D claims for 170 patients. 97% of them were for generic drugs. CMS names the drug for 684 of them, across 10 drugs with 11 or more claims each, at $17,844 in total drug cost. In 2023, CMS named 583 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Gopalakrishna for performance year 2024, reported as part of a group. Dr. Gopalakrishna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gopalakrishna as offering telehealth.

Dmand AI links 12 papers to Dr. Gopalakrishna, published from 2015 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Alzheimer Disease, Cognitive Dysfunction and Dementia. Dr. Gopalakrishna has published most often in Prim Care Companion CNS Disord. Dr. Gopalakrishna's most frequent co-authors are Stephen A. Brunton, MD, Muaid Hilmi Ithman, MD and John Lauriello, MD.

CMS Open Payments shows 21 general payments to Dr. Gopalakrishna from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 44% of the total. Eisai Inc. paid the most, $1,351.

Dr. Gopalakrishna graduated from Bangalore Medical College in 2005. Dr. Gopalakrishna is a member of APA.

Dr. Gopalakrishna is in network with 10 carriers, including Aetna, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.